A reporter in the biotech/pharma role will help us make sense of a field forever changed by the pandemic.
We’re looking for a reporter who can get inside companies and make an impact. Our reporting has already forced insurers to change their policies, giving sick kids access to life-saving drugs. We’ve brought readers deep dives on how GlaxoSmithKline stumbled in its COVID-19 vaccine work and have been the first to spot trends like how biotech founders are turning to tech investors to fund their riskiest stages.
We’re looking for someone who can deliver major stories like these, break news, and get the real story on what’s going on inside pharma and biotech companies. The job requires traditional beat reporting, investigative work, and analysis.
The salary range for this position is $75,000-$100,000. Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies and experience and may fall outside of the range shown. Insider offers a competitive total rewards package, which includes a 401k match, healthcare coverage and a broad range of other benefits.
Are you passionate about this opportunity, but worried that you don’t have 100% of the experience we’re looking for? We still want to hear from you! Apply online and let us know why you would make a great addition to the Insider community.
To apply, go here.
CNBC senior vice president Dan Colarusso sent out the following on Monday: Before this year comes to…
Business Insider editor in chief Jamie Heller sent out the following on Monday: I'm excited to share…
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…